跳至主要内容
临床试验/JPRN-UMIN000023756
JPRN-UMIN000023756未知未知

Vascular function and Antiplatelet effects on switching from Clopidgrel to Prasugrel in chronic phase after percutaneous coronary intervention - Switch-Pras study

Department of Cardiovascular Medicine,Dokkyo Medical University0 个研究点目标入组 100 人开始时间: 2016年9月1日最近更新:
适应症

试验速览

阶段
未知
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 85years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1:Ptients who has high risk for bleeding 2:Patients with heart Valve Disease and congenital heart disease 3:Patients with cerebrovascular disease 4:Patients who have infection or Inflammatory disease 5:Patients with malignant neoplasm 6:CKD <G4 eGFR<30(ml/min/1.7m2) 7:Patients with allergy against thienopyridines 8:Patients undergoing anticoagulation therapy 9:Patients who are not suitable for this study

研究者

发起方
Department of Cardiovascular Medicine,Dokkyo Medical University

相似试验

Vascular function and Antiplatelet effects on... | 临床试验